data_1r9k_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1r9k _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 120.966 0.413 . . . . 0.97999999999999998 110.2 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -141.73 117.72 1.23 Allowed Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.6 -1.4 . . . . 0.80000000000000004 109.6 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -167.56 167.41 13.55 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.358 -1.084 . . . . 1.75 110.884 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.71 23.01 3.25 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.292 -0.88 . . . . 1.6799999999999999 110.601 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.59 ' C ' ' HG ' ' A' ' 78' ' ' LEU . 19.4 t -134.64 -40.69 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.724 -0.61 . . . . 1.3100000000000001 109.695 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.59 ' HG ' ' C ' ' A' ' 77' ' ' VAL . 3.2 pp 36.79 28.82 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 113.749 1.018 . . . . 1.29 113.749 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.5 t -69.58 -176.61 1.04 Allowed 'General case' 0 N--CA 1.506 2.365 0 O-C-N 120.951 -1.093 . . . . 1.29 110.374 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.581 ' O ' ' HB3' ' A' ' 81' ' ' LYS . 0.2 OUTLIER 46.41 75.57 0.12 Allowed 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 108.109 -1.071 . . . . 1.47 108.109 -179.101 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.592 ' O ' ' HB2' ' A' ' 85' ' ' ASP . 0.0 OUTLIER 79.04 91.22 0.06 Allowed 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 106.198 -1.779 . . . . 0.81999999999999995 106.198 -175.429 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.449 ' CG2' ' O ' ' A' ' 78' ' ' LEU 0.268 40.4 p -101.11 -60.01 1.6 Allowed 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 123.035 1.398 . . . . 0.72999999999999998 108.795 -178.017 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.643 ' O ' ' N ' ' A' ' 87' ' ' MET 0.333 40.9 t -75.04 -48.99 29.96 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 N-CA-C 104.765 -2.309 . . . . 1.2 104.765 176.453 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.681 ' O ' ' HB2' ' A' ' 88' ' ' LEU 0.283 1.2 tttt -44.46 -34.29 2.0 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 112.749 -2.023 . . . . 2.0 107.621 176.651 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.592 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 5.3 t70 -78.29 -49.38 13.77 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.805 0.812 . . . . 0.40999999999999998 110.629 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.586 ' CD2' ' HE2' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -68.72 -30.53 69.19 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 108.305 -0.998 . . . . 0.44 108.305 178.687 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.643 ' N ' ' O ' ' A' ' 83' ' ' VAL . 43.4 ttm -71.98 -35.77 69.61 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.456 -1.683 . . . . 1.3200000000000001 106.456 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.681 ' HB2' ' O ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -68.76 -41.35 79.01 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.505 -0.77 . . . . 1.1699999999999999 109.902 177.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.55 ' O ' ' HB3' ' A' ' 93' ' ' SER . 0.0 OUTLIER -67.0 -43.8 81.97 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.574 -1.269 . . . . 1.1399999999999999 107.574 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -59.5 -54.7 43.62 Favored 'General case' 0 C--O 1.191 -2.001 0 N-CA-C 107.311 -1.366 . . . . 0.58999999999999997 107.311 177.287 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.525 ' HB3' ' O ' ' A' ' 88' ' ' LEU . 7.4 tp -41.64 -48.83 4.15 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.644 0.735 . . . . 1.1699999999999999 110.81 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -74.5 -44.66 50.36 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.733 0.778 . . . . 0.46999999999999997 110.244 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.55 ' HB3' ' O ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -78.03 -11.28 59.89 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.082 -0.647 . . . . 0.55000000000000004 111.511 -178.503 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.598 ' N ' ' O ' ' A' ' 90' ' ' LYS 0.25 0.4 OUTLIER -76.02 -24.44 55.25 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 106.851 -1.537 . . . . 1.3400000000000001 106.851 177.127 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.455 ' OD2' ' HA3' ' A' ' 98' ' ' GLY . 44.2 t0 44.2 63.13 1.73 Allowed 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 122.715 1.245 . . . . 0.38 110.861 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.732 HG12 ' CD1' ' A' ' 172' ' ' PHE 0.324 15.8 mt -47.04 -38.22 4.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 CA-C-N 114.426 -1.261 . . . . 1.25 109.829 178.65 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' A' ' 101' ' ' SER . 21.4 pttm -78.88 -34.67 44.64 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.069 -1.019 . . . . 0.66000000000000003 110.741 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.455 ' HA3' ' OD2' ' A' ' 95' ' ' ASP . . . -59.56 -41.46 97.26 Favored Glycine 0 C--N 1.273 -2.933 0 N-CA-C 107.806 -2.118 . . . . 0.34999999999999998 107.806 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.783 ' HB2' ' CE1' ' A' ' 106' ' ' TYR . 1.3 m120 -69.22 -42.45 75.69 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 106.358 -1.719 . . . . 0.44 106.358 177.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.422 ' HB3' ' HA ' ' A' ' 107' ' ' ALA . . . -60.17 -23.72 64.18 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.846 -0.798 . . . . 1.1000000000000001 108.846 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 97' ' ' LYS . 5.8 t -81.14 -38.01 27.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.259 -0.901 . . . . 1.0600000000000001 109.819 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.404 ' HB3' ' HE3' ' A' ' 102' ' ' LYS . 14.9 ttpp -89.85 -28.42 19.28 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.886 0.851 . . . . 0.63 110.167 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.545 ' HB3' ' HB2' ' A' ' 106' ' ' TYR . 2.2 m-20 -115.54 103.91 53.6 Favored Pre-proline 0 C--N 1.291 -1.976 0 CA-C-O 121.252 0.548 . . . . 0.58999999999999997 111.574 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.46 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 55.5 Cg_endo -71.04 -5.62 17.39 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 124.031 1.543 . . . . 0.46999999999999997 109.533 177.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -96.55 -39.6 9.46 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 105.709 -1.96 . . . . 0.46999999999999997 105.709 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.783 ' CE1' ' HB2' ' A' ' 99' ' ' ASN . 26.1 t80 -60.02 -44.9 94.29 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 113.939 -1.482 . . . . 0.40999999999999998 108.582 177.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.581 ' O ' ' HB2' ' A' ' 111' ' ' CYS . . . -63.04 -38.71 92.28 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.181 -0.918 . . . . 1.02 109.797 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 104' ' ' PRO . 41.7 mtm180 -85.51 -37.35 19.76 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 113.197 0.814 . . . . 0.76000000000000001 113.197 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.444 ' NE2' ' HA ' ' A' ' 109' ' ' GLN . 2.5 mm100 -77.55 -32.17 53.73 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.15 -0.969 . . . . 0.68000000000000005 110.694 -178.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.663 HG22 ' CE1' ' A' ' 172' ' ' PHE . 0.2 OUTLIER -94.24 1.74 55.97 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.608 -0.683 . . . . 0.33000000000000002 110.114 179.292 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . 0.581 ' HB2' ' O ' ' A' ' 107' ' ' ALA . 0.5 OUTLIER -89.79 -36.44 15.14 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 107.875 -1.157 . . . . 0.94999999999999996 107.875 177.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.641 ' HB3' ' HB3' ' A' ' 153' ' ' LEU . 2.0 mt-10 -89.04 -37.48 15.11 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.768 -0.651 . . . . 0.57999999999999996 109.319 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.533 ' HB2' ' HG3' ' A' ' 171' ' ' PRO . . . -67.48 -27.61 67.16 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 119.41 -0.916 . . . . 0.82999999999999996 112.017 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.676 HG23 ' CZ ' ' A' ' 213' ' ' PHE . 0.1 OUTLIER -62.61 -49.55 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 CA-C-O 122.388 1.09 . . . . 0.37 108.545 177.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.659 ' HA ' HG21 ' A' ' 118' ' ' VAL . 6.6 mt -77.81 -17.4 57.49 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.326 -1.361 . . . . 0.97999999999999998 107.326 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.613 ' HB3' ' O ' ' A' ' 112' ' ' GLU . 0.9 OUTLIER -78.9 -17.25 55.86 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 106.759 -1.571 . . . . 0.40000000000000002 106.759 173.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.515 ' HB3' ' HB2' ' A' ' 170' ' ' ASN . . . -76.13 -44.02 40.42 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.723 -1.214 . . . . 0.40999999999999998 107.723 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.659 HG21 ' HA ' ' A' ' 115' ' ' LEU 0.257 11.8 m -66.13 -37.4 79.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 107.181 -1.415 . . . . 0.41999999999999998 107.181 176.405 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.577 ' N ' HG23 ' A' ' 118' ' ' VAL . 3.1 t80 -55.36 -55.85 26.88 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 114.321 -1.309 . . . . 0.41999999999999998 107.473 175.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.649 ' HA ' ' HD2' ' A' ' 123' ' ' LYS . 42.6 t -68.99 -40.7 78.6 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.406 -0.816 . . . . 0.68999999999999995 109.621 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.669 ' O ' ' HB3' ' A' ' 125' ' ' GLN . 1.2 m-80 -57.07 -39.29 74.66 Favored 'General case' 0 C--O 1.192 -1.928 0 N-CA-C 106.573 -1.639 . . . . 0.39000000000000001 106.573 177.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.595 ' ND2' HG21 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -60.96 -43.63 98.44 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.639 -0.824 . . . . 0.33000000000000002 109.714 178.033 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.649 ' HD2' ' HA ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -74.82 -12.7 60.45 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 118.115 -1.434 . . . . 0.81999999999999995 109.112 179.636 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.591 ' O ' ' HB2' ' A' ' 128' ' ' LYS 0.264 32.3 t70 -95.64 -43.78 7.76 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 122.479 1.133 . . . . 0.81000000000000005 109.513 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.669 ' HB3' ' O ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER -73.58 -48.96 28.81 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 114.741 -1.118 . . . . 1.1899999999999999 109.007 -179.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.601 ' N ' ' HG2' ' A' ' 125' ' ' GLN . 17.6 t -67.21 -53.55 29.23 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.787 -0.819 . . . . 1.01 108.787 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.695 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 42.6 t -58.78 -28.4 65.92 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 119.418 -0.913 . . . . 1.03 111.342 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -53.83 -57.51 10.65 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.098 -1.001 . . . . 1.26 110.666 -179.531 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.686 ' HG ' ' N ' ' A' ' 130' ' ' LEU . 0.3 OUTLIER -78.61 -26.07 45.26 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 122.145 0.974 . . . . 1.1599999999999999 109.923 179.349 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.773 ' HB3' HG11 ' A' ' 135' ' ' VAL . 6.7 mt -67.64 -37.31 82.26 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.541 0.686 . . . . 1.1499999999999999 110.934 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.8 tp -64.27 -12.0 11.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.371 -0.974 . . . . 1.48 108.371 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.5 p -90.07 -34.74 15.81 Favored 'General case' 0 C--N 1.314 -0.973 0 O-C-N 121.798 -0.564 . . . . 0.83999999999999997 109.98 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.449 ' NZ ' ' O ' ' A' ' 237' ' ' GLN . 15.4 mttt -81.02 -24.22 38.07 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.907 0.861 . . . . 0.88 109.092 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.92 38.4 10.42 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 107.382 -2.287 . . . . 0.85999999999999999 107.382 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.773 HG11 ' HB3' ' A' ' 130' ' ' LEU 0.296 0.3 OUTLIER -82.82 -150.03 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-O 122.405 1.098 . . . . 1.01 112.332 -177.592 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.607 ' N ' ' CG1' ' A' ' 135' ' ' VAL . 0.1 OUTLIER -147.89 101.62 3.32 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.27 -1.011 . . . . 0.89000000000000001 108.27 178.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.485 HG21 HD12 ' A' ' 130' ' ' LEU . 2.1 pt -76.9 -15.67 14.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 O-C-N 121.678 -0.639 . . . . 1.2 111.674 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.621 ' N ' ' HD2' ' A' ' 139' ' ' PRO . 18.6 m -54.75 -48.82 94.5 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.56 -0.713 . . . . 0.91000000000000003 109.25 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.64 ' O ' ' HB3' ' A' ' 142' ' ' LYS . 34.6 Cg_endo -61.84 -38.53 58.71 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 N-CA-C 108.869 -1.243 . . . . 0.58999999999999997 108.869 177.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.639 ' HD1' ' CG2' ' A' ' 231' ' ' ILE . 4.3 t80 -68.35 -43.32 77.72 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.017 -1.105 . . . . 0.42999999999999999 108.017 176.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.603 ' HA ' ' CD1' ' A' ' 144' ' ' ILE . 0.5 OUTLIER -55.49 -39.98 71.11 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.495 -1.298 . . . . 1.27 107.495 176.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.64 ' HB3' ' O ' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -53.02 -40.64 64.01 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.95 -0.759 . . . . 0.52000000000000002 108.95 177.196 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.552 ' CB ' ' CG2' ' A' ' 231' ' ' ILE . 0.4 OUTLIER -70.31 -54.94 10.53 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 121.434 -0.791 . . . . 0.47999999999999998 110.497 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.783 ' CG2' HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -58.67 -30.02 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 117.65 -1.62 . . . . 0.69999999999999996 109.016 178.467 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.777 ' HA2' ' HB3' ' A' ' 148' ' ' ALA . . . -62.84 -25.53 67.78 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.617 -1.793 . . . . 0.28999999999999998 108.617 176.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.443 ' O ' ' HB3' ' A' ' 150' ' ' ASN 0.256 6.5 tp10 -65.83 -60.29 3.02 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 123.372 1.558 . . . . 0.42999999999999999 106.998 177.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.514 ' HB1' ' CE1' ' A' ' 224' ' ' PHE . . . -55.03 -40.41 70.19 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 112.985 -1.916 . . . . 1.04 106.21 176.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.777 ' HB3' ' HA2' ' A' ' 145' ' ' GLY . . . -68.55 -15.54 63.57 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.248 0.547 . . . . 0.28999999999999998 110.946 178.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.463 ' N ' ' O ' ' A' ' 145' ' ' GLY . 12.4 tt0 -97.52 -44.48 6.8 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 123.167 1.461 . . . . 0.40999999999999998 107.97 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.489 ' ND2' ' HA ' ' A' ' 147' ' ' ALA 0.251 0.0 OUTLIER -73.54 -29.79 62.67 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 113.627 -1.624 . . . . 0.46000000000000002 110.343 179.813 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.59 ' HB1' ' CE1' ' A' ' 224' ' ' PHE . . . -73.4 -18.4 61.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.382 -0.824 . . . . 0.40000000000000002 110.184 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.428 ' C ' ' HD3' ' A' ' 154' ' ' PRO . . . 107.32 18.14 10.67 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.969 -1.11 . . . . 0.41999999999999998 112.745 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.641 ' HB3' ' HB3' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -127.26 68.95 73.72 Favored Pre-proline 0 N--CA 1.51 2.532 0 CA-C-N 119.25 1.525 . . . . 1.1699999999999999 111.646 179.161 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.491 ' HA ' ' CZ ' ' A' ' 162' ' ' PHE . 51.3 Cg_endo -97.15 179.76 0.41 Allowed 'Trans proline' 0 C--N 1.317 -1.1 0 C-N-CA 122.306 2.004 . . . . 0.57999999999999996 111.088 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 149.19 -7.53 0.87 Allowed Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.708 -1.234 . . . . 0.56999999999999995 112.783 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.657 ' CB ' ' HB ' ' A' ' 163' ' ' THR . 0.1 OUTLIER -145.61 146.98 31.56 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 120.661 -1.493 . . . . 0.90000000000000002 111.038 -179.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.683 ' HA ' ' HA ' ' A' ' 162' ' ' PHE 0.269 0.0 OUTLIER -162.51 146.44 3.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.553 -0.717 . . . . 1.01 109.442 -179.207 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.538 ' HB2' HG12 ' A' ' 161' ' ' VAL . 0.9 OUTLIER -139.42 -132.5 0.12 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.748 -1.22 . . . . 0.68999999999999995 111.055 -178.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -63.3 76.87 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.24 -0.913 . . . . 1.54 111.448 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 64.89 31.25 80.31 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.167 -1.173 . . . . 0.81999999999999995 110.167 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.583 ' O ' HG12 ' A' ' 157' ' ' ILE . 1.2 p -139.57 146.05 25.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.873 -0.78 . . . . 1.1000000000000001 110.126 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.683 ' HA ' ' HA ' ' A' ' 157' ' ' ILE . 0.1 OUTLIER -122.4 154.59 37.52 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.194 0.997 . . . . 0.56000000000000005 110.745 179.346 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.657 ' HB ' ' CB ' ' A' ' 156' ' ' GLU . 3.6 m -131.93 139.59 35.53 Favored Pre-proline 0 C--N 1.296 -1.748 0 N-CA-C 108.188 -1.041 . . . . 0.66000000000000003 108.188 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.54 ' HG2' ' HB3' ' A' ' 167' ' ' ALA . 38.2 Cg_endo -64.86 149.25 89.84 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.437 1.23 . . . . 0.38 111.273 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -62.87 -83.87 0.07 OUTLIER Glycine 0 N--CA 1.499 2.854 0 N-CA-C 111.043 -0.823 . . . . 0.48999999999999999 111.043 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -73.13 66.77 1.48 Allowed Glycine 0 N--CA 1.5 2.936 0 N-CA-C 109.914 -1.274 . . . . 0.68999999999999995 109.914 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.54 ' HB3' ' HG2' ' A' ' 164' ' ' PRO . . . -102.76 98.87 8.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.675 -0.897 . . . . 1.3400000000000001 110.389 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -123.92 -141.36 5.78 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.798 -0.921 . . . . 0.58999999999999997 110.798 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 170' ' ' ASN . . . -113.56 45.32 1.44 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.669 -0.9 . . . . 1.1799999999999999 110.67 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.599 ' HB3' ' HB ' ' A' ' 173' ' ' VAL . 11.5 t-20 71.32 102.49 0.03 OUTLIER Pre-proline 0 N--CA 1.508 2.452 0 O-C-N 121.888 -0.508 . . . . 0.42999999999999999 112.053 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.587 ' HG2' ' CG2' ' A' ' 110' ' ' THR . 40.4 Cg_endo -66.03 -21.88 55.81 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 O-C-N 123.544 1.286 . . . . 0.42999999999999999 111.604 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.732 ' CD1' HG12 ' A' ' 96' ' ' ILE . 28.0 m-85 -80.16 -48.09 13.7 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.407 -0.96 . . . . 0.47999999999999998 108.407 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 170' ' ' ASN . 37.4 t -70.79 -35.89 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-N 115.978 -0.555 . . . . 1.1699999999999999 111.508 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.559 ' HB ' ' HD3' ' A' ' 175' ' ' PRO . 2.9 t -44.5 -61.76 1.95 Allowed Pre-proline 0 N--CA 1.501 2.115 0 O-C-N 121.007 -1.058 . . . . 1.1100000000000001 111.486 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.559 ' HD3' ' HB ' ' A' ' 174' ' ' VAL . 40.4 Cg_endo -75.88 -26.54 9.47 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 O-C-N 123.048 1.026 . . . . 0.40000000000000002 110.716 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.723 HD22 HG12 ' A' ' 177' ' ' ILE . 0.4 OUTLIER -63.82 -51.74 63.33 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 105.785 -1.932 . . . . 1.1200000000000001 105.785 177.504 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.723 HG12 HD22 ' A' ' 176' ' ' LEU . 5.5 mm -71.97 -31.11 39.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-N 114.953 -1.021 . . . . 1.25 109.701 177.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.479 ' HB2' ' HA ' ' A' ' 175' ' ' PRO . . . -64.18 -42.78 96.53 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.132 -1.062 . . . . 0.56999999999999995 108.132 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 183' ' ' LYS . 25.4 p -63.37 -51.98 63.64 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.594 -0.842 . . . . 0.53000000000000003 108.853 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.605 ' HB2' ' CZ ' ' A' ' 188' ' ' PHE . . . -61.75 -24.92 67.13 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 121.714 -0.616 . . . . 0.55000000000000004 111.509 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.403 ' HA ' ' CD2' ' A' ' 188' ' ' PHE . 65.9 m -77.35 -32.23 54.93 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.117 -1.438 . . . . 0.73999999999999999 107.117 177.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.46 ' HB ' ' O ' ' A' ' 178' ' ' ALA 0.31 0.1 OUTLIER -81.23 -35.51 14.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 114.389 -1.278 . . . . 1.3 109.177 178.018 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.956 ' HG2' ' CD2' ' A' ' 184' ' ' TYR 0.262 0.0 OUTLIER -81.85 -54.44 5.35 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.065 -0.971 . . . . 0.63 110.651 -178.812 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.956 ' CD2' ' HG2' ' A' ' 183' ' ' LYS . 42.7 m-85 -100.96 83.36 0.41 Allowed Pre-proline 0 C--N 1.292 -1.925 0 CA-C-N 115.503 -0.771 . . . . 0.67000000000000004 112.993 -178.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.19 -40.41 8.71 Favored 'Trans proline' 0 C--N 1.299 -2.079 0 N-CA-C 107.596 -1.732 . . . . 0.92000000000000004 107.596 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.621 ' HA ' ' CD1' ' A' ' 189' ' ' ILE . 22.7 t60 -56.46 -48.97 75.95 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 113.536 0.939 . . . . 1.1799999999999999 113.536 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' MET . . . . . 0.607 ' HB3' ' CE2' ' A' ' 197' ' ' PHE . 1.9 mmt -79.33 -25.49 42.32 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 121.549 0.69 . . . . 1.6899999999999999 110.233 -178.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . 0.605 ' CZ ' ' HB2' ' A' ' 180' ' ' ALA . 28.0 m-85 -95.07 -2.66 49.68 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.384 -0.822 . . . . 0.81999999999999995 111.475 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.621 ' CD1' ' HA ' ' A' ' 186' ' ' HIS . 0.5 OUTLIER -53.56 -47.35 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 O-C-N 121.487 -0.758 . . . . 1.54 111.194 179.429 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.422 ' HB2' ' OE1' ' A' ' 193' ' ' GLN . 10.5 m-20 -68.26 131.93 46.23 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 122.064 0.935 . . . . 1.6799999999999999 110.96 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.546 ' C ' ' CD2' ' A' ' 191' ' ' HIS . 0.1 OUTLIER -54.28 -29.22 46.47 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.526 -0.761 . . . . 1.4399999999999999 111.773 -178.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -94.89 -16.76 22.62 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.676 -1.265 . . . . 1.5600000000000001 111.797 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.447 ' HB3' ' O ' ' A' ' 187' ' ' MET . 19.1 mt-30 -68.27 -46.63 69.88 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.881 -1.137 . . . . 1.45 111.729 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . 0.531 ' HB2' ' HD2' ' A' ' 188' ' ' PHE . 0.0 OUTLIER -68.66 -27.85 66.36 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.501 -1.375 . . . . 0.97999999999999998 109.266 179.015 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.591 ' HA ' ' HD3' ' A' ' 198' ' ' LYS . 0.9 OUTLIER -72.18 -42.68 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 107.696 -1.224 . . . . 1.46 107.696 177.112 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.96 -33.7 68.4 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.154 -0.966 . . . . 1.3700000000000001 109.348 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.623 ' HB3' ' CD1' ' A' ' 177' ' ' ILE . 0.4 OUTLIER -53.72 -44.4 69.85 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.506 0.669 . . . . 0.66000000000000003 111.038 179.393 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.591 ' HD3' ' HA ' ' A' ' 195' ' ' VAL . 3.6 pttm -70.64 -16.11 62.79 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.212 0.529 . . . . 1.22 110.539 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.496 ' O ' ' HG3' ' A' ' 202' ' ' GLU . . . -71.43 -50.72 29.0 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.272 -0.971 . . . . 1.3100000000000001 109.908 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.609 ' CE1' ' CG ' ' A' ' 84' ' ' LYS . 4.4 p90 -79.86 -11.69 59.8 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 117.685 -1.606 . . . . 0.58999999999999997 107.973 176.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.647 ' HB2' ' CD2' ' A' ' 176' ' ' LEU . . . -73.27 -41.69 63.33 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.691 -0.855 . . . . 0.90000000000000002 108.691 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.593 ' O ' HG23 ' A' ' 205' ' ' VAL . 0.0 OUTLIER -69.29 -16.98 63.68 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.195 -1.402 . . . . 1.1399999999999999 108.992 178.341 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -78.9 -32.06 45.61 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.97 -1.081 . . . . 0.84999999999999998 111.376 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 201' ' ' ALA . 5.4 pt -77.11 -43.4 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 120.8 -1.188 . . . . 1.1299999999999999 110.136 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 202' ' ' GLU . 25.3 m -50.26 -33.4 10.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 C-N-CA 119.116 -1.033 . . . . 1.1000000000000001 108.736 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' MET . . . . . 0.801 ' HA ' ' CG2' ' A' ' 209' ' ' VAL . 0.8 OUTLIER -53.99 -16.81 2.1 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.872 -0.731 . . . . 2.0899999999999999 111.125 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.587 ' HG3' ' N ' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -88.78 -24.43 22.63 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.509 -1.293 . . . . 0.68999999999999995 107.509 176.574 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.587 ' N ' ' HG3' ' A' ' 207' ' ' LYS . 17.8 tp10 -100.67 -38.43 8.33 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 116.084 -0.507 . . . . 0.63 110.675 178.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.801 ' CG2' ' HA ' ' A' ' 206' ' ' MET . 34.2 m -75.01 -30.95 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.208 -0.932 . . . . 0.53000000000000003 112.421 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.63 ' N ' ' HD2' ' A' ' 211' ' ' PRO . 1.3 m -43.45 -45.97 16.16 Favored Pre-proline 0 N--CA 1.51 2.552 0 O-C-N 120.942 -1.099 . . . . 1.1499999999999999 112.142 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' A' ' 210' ' ' THR . 38.1 Cg_endo -60.9 -24.5 79.45 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 O-C-N 122.891 0.943 . . . . 0.39000000000000001 112.706 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.65 ' N ' HD21 ' A' ' 212' ' ' LEU . 0.8 OUTLIER -75.11 -18.24 60.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.408 -1.433 . . . . 1.05 107.461 176.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . 0.676 ' CZ ' HG23 ' A' ' 114' ' ' ILE . 4.6 m-30 -89.57 3.17 53.37 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.437 -0.801 . . . . 0.41999999999999998 109.68 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -83.1 -43.1 16.63 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.434 -0.792 . . . . 1.52 109.375 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.76 136.19 38.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.402 -0.811 . . . . 0.45000000000000001 110.219 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 91.66 -125.61 8.12 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.114 -1.194 . . . . 0.46000000000000002 110.114 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 21.4 p -148.8 35.15 0.76 Allowed 'General case' 0 N--CA 1.509 2.476 0 O-C-N 121.609 -0.936 . . . . 1.1499999999999999 110.171 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.86 144.98 69.36 Favored Pre-proline 0 C--N 1.291 -1.952 0 O-C-N 121.808 -0.557 . . . . 1.46 112.057 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.493 ' HB2' ' HB2' ' A' ' 224' ' ' PHE . 56.2 Cg_endo -78.66 158.8 28.42 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 O-C-N 123.837 1.441 . . . . 0.34000000000000002 108.457 178.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' THR . . . . . 0.507 ' OG1' ' HB3' ' A' ' 223' ' ' GLN . 0.0 OUTLIER -80.77 161.81 62.43 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 120.669 -1.269 . . . . 1.04 107.703 178.824 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.608 ' HD3' ' CD2' ' A' ' 213' ' ' PHE . 34.1 Cg_endo -59.69 -44.86 28.52 Favored 'Trans proline' 0 C--N 1.294 -2.342 0 O-C-N 123.791 1.416 . . . . 0.32000000000000001 109.478 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.491 ' O ' ' HB2' ' A' ' 226' ' ' LEU . 41.9 tt0 -71.02 -42.11 69.99 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 120.24 -0.584 . . . . 1.8 111.81 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . 0.507 ' HB3' ' OG1' ' A' ' 220' ' ' THR . 0.0 OUTLIER -66.77 -44.7 80.67 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.049 -1.093 . . . . 0.40000000000000002 108.049 178.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.59 ' CE1' ' HB1' ' A' ' 151' ' ' ALA . 62.1 t80 -73.08 -43.49 61.76 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.688 -0.633 . . . . 0.35999999999999999 109.951 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . 0.631 ' HA ' HG22 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -59.04 -47.37 85.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -0.92 . . . . 0.83999999999999997 109.711 179.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.1 OUTLIER -59.65 -49.98 75.65 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 119.288 -0.965 . . . . 1.8200000000000001 109.325 179.099 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 25.6 m -58.07 -33.25 68.84 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.871 -0.731 . . . . 1.1000000000000001 109.298 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.783 HG12 ' CG2' ' A' ' 144' ' ' ILE 0.264 1.7 tt -77.88 -53.42 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.053 -1.091 . . . . 0.45000000000000001 108.053 178.147 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.743 ' N ' HG21 ' A' ' 228' ' ' ILE . 5.7 mt-10 -51.37 -38.35 52.82 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.601 -1.259 . . . . 0.46999999999999997 107.601 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 0.5 OUTLIER -54.23 -25.53 23.63 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.184 -0.917 . . . . 0.60999999999999999 110.595 178.67 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.639 ' CG2' ' HD1' ' A' ' 140' ' ' PHE . 3.4 mt -94.75 -19.89 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 118.216 -1.394 . . . . 1.03 107.994 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.724 ' O ' ' HB2' ' A' ' 236' ' ' LEU . . . -78.44 -42.82 28.89 Favored 'General case' 0 C--O 1.198 -1.658 0 N-CA-C 105.589 -2.004 . . . . 0.82999999999999996 105.589 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.54 ' HA ' ' CB ' ' A' ' 236' ' ' LEU 0.275 4.8 m-80 -67.96 -31.56 71.38 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.526 -1.215 . . . . 0.55000000000000004 109.962 177.314 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.449 ' O ' ' NZ ' ' A' ' 234' ' ' LYS . 0.0 OUTLIER -70.11 -44.81 68.21 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.985 -1.116 . . . . 0.76000000000000001 107.985 179.537 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.532 ' HB3' HD11 ' A' ' 130' ' ' LEU . 0.6 OUTLIER -82.04 -17.68 45.86 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 121.773 0.797 . . . . 1.1799999999999999 109.006 177.518 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.724 ' HB2' ' O ' ' A' ' 232' ' ' ALA 0.288 24.0 tp -57.58 -60.05 4.26 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 122.358 1.075 . . . . 1.3100000000000001 110.183 178.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLN . . . . . 0.449 ' O ' ' NZ ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -68.57 -90.39 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 114.674 -1.148 . . . . 0.97999999999999998 110.273 -178.514 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.402 ' OD1' ' NZ ' ' A' ' 234' ' ' LYS . 1.6 m-20 52.38 61.32 3.26 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.34 -0.85 . . . . 0.78000000000000003 110.455 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . 69.15 -51.67 0.6 Allowed 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.7 -0.625 . . . . 1.28 109.839 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.96 0 CA-C-O 117.707 -1.14 . . . . 1.1699999999999999 110.942 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 120.966 0.413 . . . . 0.89000000000000001 110.2 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -141.73 117.72 1.23 Allowed Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.6 -1.4 . . . . 0.80000000000000004 109.6 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -167.56 167.41 13.55 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.358 -1.084 . . . . 1.5 110.884 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.71 23.01 3.25 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.292 -0.88 . . . . 1.1699999999999999 110.601 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.613 ' C ' ' HG ' ' A' ' 78' ' ' LEU . 19.4 t -134.64 -40.69 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.724 -0.61 . . . . 0.93000000000000005 109.695 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.822 ' O ' HG22 ' A' ' 82' ' ' THR . 3.2 pp 36.79 28.82 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 113.749 1.018 . . . . 0.63 113.749 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.5 t -69.58 -176.61 1.04 Allowed 'General case' 0 N--CA 1.506 2.365 0 O-C-N 120.951 -1.093 . . . . 0.70999999999999996 110.374 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.584 ' O ' ' HB3' ' A' ' 81' ' ' LYS . 0.2 OUTLIER 46.41 75.57 0.12 Allowed 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 108.109 -1.071 . . . . 1.03 108.109 -179.101 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.614 ' O ' ' HB2' ' A' ' 85' ' ' ASP . 0.0 OUTLIER 79.04 91.22 0.06 Allowed 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 106.198 -1.779 . . . . 0.66000000000000003 106.198 -175.429 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.822 HG22 ' O ' ' A' ' 78' ' ' LEU 0.268 40.4 p -101.11 -60.01 1.6 Allowed 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 123.035 1.398 . . . . 0.53000000000000003 108.795 -178.017 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.942 HG22 ' CD2' ' A' ' 184' ' ' TYR 0.333 40.9 t -75.04 -48.99 29.96 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 N-CA-C 104.765 -2.309 . . . . 0.46000000000000002 104.765 176.453 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.685 ' O ' ' HB2' ' A' ' 88' ' ' LEU 0.283 1.2 tttt -44.46 -34.29 2.0 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 112.749 -2.023 . . . . 1.52 107.621 176.651 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.614 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 5.3 t70 -78.29 -49.38 13.77 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.805 0.812 . . . . 0.40999999999999998 110.629 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.608 ' HE2' ' HB2' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -68.72 -30.53 69.19 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 108.305 -0.998 . . . . 0.39000000000000001 108.305 178.687 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.643 ' N ' ' O ' ' A' ' 83' ' ' VAL . 43.4 ttm -71.98 -35.77 69.61 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.456 -1.683 . . . . 0.68999999999999995 106.456 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.685 ' HB2' ' O ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -68.76 -41.35 79.01 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.505 -0.77 . . . . 0.52000000000000002 109.902 177.897 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.544 ' O ' ' HB3' ' A' ' 93' ' ' SER . 0.0 OUTLIER -67.0 -43.8 81.97 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.574 -1.269 . . . . 1.1399999999999999 107.574 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -59.5 -54.7 43.62 Favored 'General case' 0 C--O 1.191 -2.001 0 N-CA-C 107.311 -1.366 . . . . 0.45000000000000001 107.311 177.287 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.687 HD11 ' HA ' ' A' ' 205' ' ' VAL . 7.4 tp -41.64 -48.83 4.15 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.644 0.735 . . . . 0.57999999999999996 110.81 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -74.5 -44.66 50.36 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.733 0.778 . . . . 0.45000000000000001 110.244 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.544 ' HB3' ' O ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -78.03 -11.28 59.89 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.082 -0.647 . . . . 0.46000000000000002 111.511 -178.503 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.598 ' N ' ' O ' ' A' ' 90' ' ' LYS 0.25 0.4 OUTLIER -76.02 -24.44 55.25 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 106.851 -1.537 . . . . 0.65000000000000002 106.851 177.127 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.494 ' OD2' ' HA3' ' A' ' 98' ' ' GLY . 44.2 t0 44.2 63.13 1.73 Allowed 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 122.715 1.245 . . . . 0.38 110.861 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.936 HG22 HD11 ' A' ' 212' ' ' LEU 0.324 15.8 mt -47.04 -38.22 4.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 CA-C-N 114.426 -1.261 . . . . 0.52000000000000002 109.829 178.65 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.431 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 21.4 pttm -78.88 -34.67 44.64 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.069 -1.019 . . . . 0.54000000000000004 110.741 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.494 ' HA3' ' OD2' ' A' ' 95' ' ' ASP . . . -59.56 -41.46 97.26 Favored Glycine 0 C--N 1.273 -2.933 0 N-CA-C 107.806 -2.118 . . . . 0.31 107.806 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.801 ' HB2' ' CE1' ' A' ' 106' ' ' TYR . 2.1 m-20 -69.22 -42.45 75.69 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 106.358 -1.719 . . . . 0.44 106.358 177.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.458 ' CA ' ' HB2' ' A' ' 107' ' ' ALA . . . -60.17 -23.72 64.18 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.846 -0.798 . . . . 0.33000000000000002 108.846 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 97' ' ' LYS . 5.8 t -81.14 -38.01 27.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.259 -0.901 . . . . 0.51000000000000001 109.819 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.403 ' HB3' ' HE3' ' A' ' 102' ' ' LYS . 14.9 ttpp -89.85 -28.42 19.28 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.886 0.851 . . . . 0.51000000000000001 110.167 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' A' ' 106' ' ' TYR . 2.2 m-20 -115.54 103.91 53.6 Favored Pre-proline 0 C--N 1.291 -1.976 0 CA-C-O 121.252 0.548 . . . . 0.58999999999999997 111.574 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.494 ' HD2' ' HA ' ' A' ' 103' ' ' ASP . 55.5 Cg_endo -71.04 -5.62 17.39 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 124.031 1.543 . . . . 0.41999999999999998 109.533 177.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -96.55 -39.6 9.46 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 105.709 -1.96 . . . . 0.34999999999999998 105.709 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.801 ' CE1' ' HB2' ' A' ' 99' ' ' ASN . 26.1 t80 -60.02 -44.9 94.29 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 113.939 -1.482 . . . . 0.34000000000000002 108.582 177.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.579 ' O ' ' HB2' ' A' ' 111' ' ' CYS . . . -63.04 -38.71 92.28 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.181 -0.918 . . . . 0.32000000000000001 109.797 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 104' ' ' PRO . 41.7 mtm180 -85.51 -37.35 19.76 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 113.197 0.814 . . . . 0.64000000000000001 113.197 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.421 ' NE2' ' HA ' ' A' ' 109' ' ' GLN . 2.5 mm100 -77.55 -32.17 53.73 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.15 -0.969 . . . . 0.56999999999999995 110.694 -178.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.622 HG21 ' CE1' ' A' ' 172' ' ' PHE . 0.2 OUTLIER -94.24 1.74 55.97 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.608 -0.683 . . . . 0.28000000000000003 110.114 179.292 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' CYS . . . . . 0.579 ' HB2' ' O ' ' A' ' 107' ' ' ALA . 0.5 OUTLIER -89.79 -36.44 15.14 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 107.875 -1.157 . . . . 0.35999999999999999 107.875 177.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.661 ' HB3' ' HB3' ' A' ' 153' ' ' LEU . 2.0 mt-10 -89.04 -37.48 15.11 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.768 -0.651 . . . . 0.57999999999999996 109.319 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.588 ' HA ' ' CB ' ' A' ' 116' ' ' SER . . . -67.48 -27.61 67.16 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 119.41 -0.916 . . . . 0.27000000000000002 112.017 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.957 HG21 ' CZ ' ' A' ' 213' ' ' PHE . 0.1 OUTLIER -62.61 -49.55 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 CA-C-O 122.388 1.09 . . . . 0.28000000000000003 108.545 177.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.843 ' O ' HG22 ' A' ' 118' ' ' VAL . 6.6 mt -77.81 -17.4 57.49 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.326 -1.361 . . . . 0.28999999999999998 107.326 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.619 ' HB3' ' O ' ' A' ' 112' ' ' GLU . 0.9 OUTLIER -78.9 -17.25 55.86 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 106.759 -1.571 . . . . 0.34000000000000002 106.759 173.744 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 114' ' ' ILE . . . -76.13 -44.02 40.42 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.723 -1.214 . . . . 0.28000000000000003 107.723 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.843 HG22 ' O ' ' A' ' 115' ' ' LEU 0.257 11.8 m -66.13 -37.4 79.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 107.181 -1.415 . . . . 0.25 107.181 176.405 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.828 ' HA ' HD11 ' A' ' 228' ' ' ILE . 3.1 t80 -55.36 -55.85 26.88 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 114.321 -1.309 . . . . 0.26000000000000001 107.473 175.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.718 ' HA ' ' HD2' ' A' ' 123' ' ' LYS . 42.6 t -68.99 -40.7 78.6 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.406 -0.816 . . . . 0.45000000000000001 109.621 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.663 ' O ' ' HB3' ' A' ' 125' ' ' GLN . 3.5 m-20 -57.07 -39.29 74.66 Favored 'General case' 0 C--O 1.192 -1.928 0 N-CA-C 106.573 -1.639 . . . . 0.39000000000000001 106.573 177.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.864 ' CG ' HG23 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -60.96 -43.63 98.44 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.639 -0.824 . . . . 0.33000000000000002 109.714 178.033 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.718 ' HD2' ' HA ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -74.82 -12.7 60.45 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 118.115 -1.434 . . . . 0.63 109.112 179.636 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.602 ' O ' ' HB2' ' A' ' 128' ' ' LYS 0.264 32.3 t70 -95.64 -43.78 7.76 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 122.479 1.133 . . . . 0.81000000000000005 109.513 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.663 ' HB3' ' O ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER -73.58 -48.96 28.81 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 114.741 -1.118 . . . . 0.78000000000000003 109.007 -179.732 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.65 ' SG ' ' HA ' ' A' ' 232' ' ' ALA . 17.6 t -67.21 -53.55 29.23 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.787 -0.819 . . . . 0.47999999999999998 108.787 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.786 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 42.6 t -58.78 -28.4 65.92 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 119.418 -0.913 . . . . 0.58999999999999997 111.342 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.602 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -53.83 -57.51 10.65 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.098 -1.001 . . . . 1.02 110.666 -179.531 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.759 ' CD2' HD12 ' A' ' 236' ' ' LEU . 0.3 OUTLIER -78.61 -26.07 45.26 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 122.145 0.974 . . . . 0.63 109.923 179.349 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 1.035 HD22 HG11 ' A' ' 135' ' ' VAL . 6.7 mt -67.64 -37.31 82.26 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.541 0.686 . . . . 0.68000000000000005 110.934 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.8 tp -64.27 -12.0 11.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.371 -0.974 . . . . 0.92000000000000004 108.371 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.5 p -90.07 -34.74 15.81 Favored 'General case' 0 C--N 1.314 -0.973 0 O-C-N 121.798 -0.564 . . . . 0.83999999999999997 109.98 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.748 ' HE3' HD12 ' A' ' 129' ' ' LEU . 15.4 mttt -81.02 -24.22 38.07 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.907 0.861 . . . . 0.84999999999999998 109.092 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.92 38.4 10.42 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 107.382 -2.287 . . . . 0.81999999999999995 107.382 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 1.035 HG11 HD22 ' A' ' 130' ' ' LEU 0.296 0.3 OUTLIER -82.82 -150.03 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-O 122.405 1.098 . . . . 0.71999999999999997 112.332 -177.592 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.876 ' N ' HG13 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -147.89 101.62 3.32 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.27 -1.011 . . . . 0.81000000000000005 108.27 178.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.455 HG23 ' H ' ' A' ' 137' ' ' ILE . 2.1 pt -76.9 -15.67 14.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 O-C-N 121.678 -0.639 . . . . 0.70999999999999996 111.674 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.633 ' N ' ' HD2' ' A' ' 139' ' ' PRO . 18.6 m -54.75 -48.82 94.5 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.56 -0.713 . . . . 0.56999999999999995 109.25 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.656 ' O ' ' HB3' ' A' ' 142' ' ' LYS . 34.6 Cg_endo -61.84 -38.53 58.71 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 N-CA-C 108.869 -1.243 . . . . 0.54000000000000004 108.869 177.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.943 ' HD1' HG22 ' A' ' 231' ' ' ILE . 4.3 t80 -68.35 -43.32 77.72 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.017 -1.105 . . . . 0.40999999999999998 108.017 176.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.735 ' HA ' HD11 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -55.49 -39.98 71.11 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.495 -1.298 . . . . 0.56999999999999995 107.495 176.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.656 ' HB3' ' O ' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -53.02 -40.64 64.01 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.95 -0.759 . . . . 0.45000000000000001 108.95 177.196 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 1.02 ' CB ' HG21 ' A' ' 231' ' ' ILE . 0.4 OUTLIER -70.31 -54.94 10.53 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 121.434 -0.791 . . . . 0.47999999999999998 110.497 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.969 HG22 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -58.67 -30.02 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 117.65 -1.62 . . . . 0.40000000000000002 109.016 178.467 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.83 ' HA2' ' HB3' ' A' ' 148' ' ' ALA . . . -62.84 -25.53 67.78 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.617 -1.793 . . . . 0.26000000000000001 108.617 176.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 150' ' ' ASN 0.256 6.5 tp10 -65.83 -60.29 3.02 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 123.372 1.558 . . . . 0.42999999999999999 106.998 177.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.679 ' HB1' ' CE1' ' A' ' 224' ' ' PHE . . . -55.03 -40.41 70.19 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 112.985 -1.916 . . . . 0.27000000000000002 106.21 176.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.849 ' HB1' ' HB3' ' A' ' 164' ' ' PRO . . . -68.55 -15.54 63.57 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.248 0.547 . . . . 0.27000000000000002 110.946 178.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.463 ' N ' ' O ' ' A' ' 145' ' ' GLY . 12.4 tt0 -97.52 -44.48 6.8 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 123.167 1.461 . . . . 0.37 107.97 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' A' ' 146' ' ' GLU 0.251 0.1 OUTLIER -73.54 -29.79 62.67 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 113.627 -1.624 . . . . 0.46000000000000002 110.343 179.813 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.661 ' HB2' ' CE1' ' A' ' 224' ' ' PHE . . . -73.4 -18.4 61.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.382 -0.824 . . . . 0.37 110.184 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.443 ' C ' ' HD3' ' A' ' 154' ' ' PRO . . . 107.32 18.14 10.67 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.969 -1.11 . . . . 0.41999999999999998 112.745 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.661 ' HB3' ' HB3' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -127.26 68.95 73.72 Favored Pre-proline 0 N--CA 1.51 2.532 0 CA-C-N 119.25 1.525 . . . . 0.45000000000000001 111.646 179.161 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.465 ' HA ' ' CZ ' ' A' ' 162' ' ' PHE . 51.3 Cg_endo -97.15 179.76 0.41 Allowed 'Trans proline' 0 C--N 1.317 -1.1 0 C-N-CA 122.306 2.004 . . . . 0.5 111.088 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 149.19 -7.53 0.87 Allowed Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.708 -1.234 . . . . 0.56000000000000005 112.783 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.676 ' CB ' ' HB ' ' A' ' 163' ' ' THR . 0.1 OUTLIER -145.61 146.98 31.56 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 120.661 -1.493 . . . . 0.90000000000000002 111.038 -179.553 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.665 ' HA ' ' HA ' ' A' ' 162' ' ' PHE 0.269 0.0 OUTLIER -162.51 146.44 3.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.553 -0.717 . . . . 0.62 109.442 -179.207 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.593 ' HB2' HG12 ' A' ' 161' ' ' VAL . 0.9 OUTLIER -139.42 -132.5 0.12 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.748 -1.22 . . . . 0.65000000000000002 111.055 -178.732 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -63.3 76.87 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.24 -0.913 . . . . 1.28 111.448 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 64.89 31.25 80.31 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.167 -1.173 . . . . 0.75 110.167 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.593 HG12 ' HB2' ' A' ' 158' ' ' LYS . 1.2 p -139.57 146.05 25.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.873 -0.78 . . . . 0.56000000000000005 110.126 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.665 ' HA ' ' HA ' ' A' ' 157' ' ' ILE . 0.1 OUTLIER -122.4 154.59 37.52 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.194 0.997 . . . . 0.42999999999999999 110.745 179.346 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.676 ' HB ' ' CB ' ' A' ' 156' ' ' GLU . 3.6 m -131.93 139.59 35.53 Favored Pre-proline 0 C--N 1.296 -1.748 0 N-CA-C 108.188 -1.041 . . . . 0.48999999999999999 108.188 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.849 ' HB3' ' HB1' ' A' ' 148' ' ' ALA . 38.2 Cg_endo -64.86 149.25 89.84 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.437 1.23 . . . . 0.34000000000000002 111.273 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -62.87 -83.87 0.07 OUTLIER Glycine 0 N--CA 1.499 2.854 0 N-CA-C 111.043 -0.823 . . . . 0.46999999999999997 111.043 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -73.13 66.77 1.48 Allowed Glycine 0 N--CA 1.5 2.936 0 N-CA-C 109.914 -1.274 . . . . 0.68000000000000005 109.914 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.739 ' HB2' ' HG2' ' A' ' 164' ' ' PRO . . . -102.76 98.87 8.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.675 -0.897 . . . . 0.65000000000000002 110.389 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -123.92 -141.36 5.78 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.798 -0.921 . . . . 0.57999999999999996 110.798 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 170' ' ' ASN . . . -113.56 45.32 1.44 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.669 -0.9 . . . . 0.54000000000000004 110.67 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.606 ' HB3' ' HB ' ' A' ' 173' ' ' VAL . 11.5 t-20 71.32 102.49 0.03 OUTLIER Pre-proline 0 N--CA 1.508 2.452 0 O-C-N 121.888 -0.508 . . . . 0.38 112.053 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.611 ' CG ' HG23 ' A' ' 110' ' ' THR . 40.4 Cg_endo -66.03 -21.88 55.81 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 O-C-N 123.544 1.286 . . . . 0.41999999999999998 111.604 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.906 ' CE1' HG23 ' A' ' 96' ' ' ILE . 28.0 m-85 -80.16 -48.09 13.7 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.407 -0.96 . . . . 0.41999999999999998 108.407 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.682 ' HA ' ' HB3' ' A' ' 176' ' ' LEU . 37.4 t -70.79 -35.89 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-N 115.978 -0.555 . . . . 0.46999999999999997 111.508 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.604 ' HB ' ' HD3' ' A' ' 175' ' ' PRO . 2.9 t -44.5 -61.76 1.95 Allowed Pre-proline 0 N--CA 1.501 2.115 0 O-C-N 121.007 -1.058 . . . . 0.46000000000000002 111.486 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.703 ' HA ' ' HB3' ' A' ' 178' ' ' ALA . 40.4 Cg_endo -75.88 -26.54 9.47 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 O-C-N 123.048 1.026 . . . . 0.34999999999999998 110.716 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.71 HD23 HG12 ' A' ' 177' ' ' ILE . 0.4 OUTLIER -63.82 -51.74 63.33 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 105.785 -1.932 . . . . 0.42999999999999999 105.785 177.504 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.71 HG12 HD23 ' A' ' 176' ' ' LEU . 5.5 mm -71.97 -31.11 39.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-N 114.953 -1.021 . . . . 0.56999999999999995 109.701 177.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.703 ' HB3' ' HA ' ' A' ' 175' ' ' PRO . . . -64.18 -42.78 96.53 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.132 -1.062 . . . . 0.56999999999999995 108.132 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 183' ' ' LYS . 25.4 p -63.37 -51.98 63.64 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.594 -0.842 . . . . 0.5 108.853 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.608 ' HB2' ' HE2' ' A' ' 86' ' ' PHE . . . -61.75 -24.92 67.13 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 121.714 -0.616 . . . . 0.55000000000000004 111.509 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 65.9 m -77.35 -32.23 54.93 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.117 -1.438 . . . . 0.73999999999999999 107.117 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.456 ' HB ' ' O ' ' A' ' 178' ' ' ALA 0.31 0.1 OUTLIER -81.23 -35.51 14.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 114.389 -1.278 . . . . 0.73999999999999999 109.177 178.018 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.994 ' HG2' ' CD2' ' A' ' 184' ' ' TYR 0.262 0.0 OUTLIER -81.85 -54.44 5.35 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.065 -0.971 . . . . 0.63 110.651 -178.812 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.994 ' CD2' ' HG2' ' A' ' 183' ' ' LYS . 42.7 m-85 -100.96 83.36 0.41 Allowed Pre-proline 0 C--N 1.292 -1.925 0 CA-C-N 115.503 -0.771 . . . . 0.67000000000000004 112.993 -178.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.19 -40.41 8.71 Favored 'Trans proline' 0 C--N 1.299 -2.079 0 N-CA-C 107.596 -1.732 . . . . 0.85999999999999999 107.596 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 1.078 ' HA ' HD12 ' A' ' 189' ' ' ILE . 22.7 t60 -56.46 -48.97 75.95 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 113.536 0.939 . . . . 1.0700000000000001 113.536 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' MET . . . . . 0.619 ' HB3' ' CE2' ' A' ' 197' ' ' PHE . 1.9 mmt -79.33 -25.49 42.32 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 121.549 0.69 . . . . 1.1200000000000001 110.233 -178.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' PHE . . . . . 0.576 ' HD2' ' HB2' ' A' ' 194' ' ' GLN . 28.0 m-85 -95.07 -2.66 49.68 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.384 -0.822 . . . . 0.81999999999999995 111.475 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 1.078 HD12 ' HA ' ' A' ' 186' ' ' HIS . 0.5 OUTLIER -53.56 -47.35 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 O-C-N 121.487 -0.758 . . . . 1.1000000000000001 111.194 179.429 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.428 ' HB2' ' OE1' ' A' ' 193' ' ' GLN . 10.5 m-20 -68.26 131.93 46.23 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 122.064 0.935 . . . . 1.6799999999999999 110.96 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.28 -29.22 46.47 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.526 -0.761 . . . . 1.3600000000000001 111.773 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -94.89 -16.76 22.62 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.676 -1.265 . . . . 1.3799999999999999 111.797 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.472 ' HB3' ' O ' ' A' ' 187' ' ' MET . 19.1 mt-30 -68.27 -46.63 69.88 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.881 -1.137 . . . . 1.0 111.729 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLN . . . . . 0.615 HE21 HG23 ' A' ' 195' ' ' VAL . 1.1 pm0 -68.66 -27.85 66.36 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.501 -1.375 . . . . 0.94999999999999996 109.266 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.673 ' HA ' ' HD3' ' A' ' 198' ' ' LYS . 0.9 OUTLIER -72.18 -42.68 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 107.696 -1.224 . . . . 0.96999999999999997 107.696 177.112 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.43 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 0.5 OUTLIER -71.96 -33.7 68.4 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.154 -0.966 . . . . 0.92000000000000004 109.348 178.585 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.648 ' HB3' ' CD1' ' A' ' 177' ' ' ILE . 0.4 OUTLIER -53.72 -44.4 69.85 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.506 0.669 . . . . 0.63 111.038 179.393 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.673 ' HD3' ' HA ' ' A' ' 195' ' ' VAL . 3.6 pttm -70.64 -16.11 62.79 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.212 0.529 . . . . 1.0900000000000001 110.539 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.515 ' O ' ' HG3' ' A' ' 202' ' ' GLU . . . -71.43 -50.72 29.0 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.272 -0.971 . . . . 0.75 109.908 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.614 ' CE1' ' HG3' ' A' ' 84' ' ' LYS . 4.4 p90 -79.86 -11.69 59.8 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 117.685 -1.606 . . . . 0.57999999999999996 107.973 176.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.66 ' HB3' ' HA ' ' A' ' 198' ' ' LYS . . . -73.27 -41.69 63.33 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.691 -0.855 . . . . 0.5 108.691 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.587 ' O ' HG22 ' A' ' 205' ' ' VAL . 0.0 OUTLIER -69.29 -16.98 63.68 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.195 -1.402 . . . . 1.1399999999999999 108.992 178.341 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 203' ' ' LYS . 1.2 tppt? -78.9 -32.06 45.61 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.97 -1.081 . . . . 0.69999999999999996 111.376 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.497 ' HB ' HD22 ' A' ' 91' ' ' LEU . 5.4 pt -77.11 -43.4 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 120.8 -1.188 . . . . 0.41999999999999998 110.136 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.943 ' O ' HG22 ' A' ' 209' ' ' VAL . 25.3 m -50.26 -33.4 10.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 C-N-CA 119.116 -1.033 . . . . 0.38 108.736 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' MET . . . . . 0.801 ' HA ' ' CG2' ' A' ' 209' ' ' VAL . 0.8 OUTLIER -53.99 -16.81 2.1 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.872 -0.731 . . . . 1.4199999999999999 111.125 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.593 ' HG3' ' N ' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -88.78 -24.43 22.63 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.509 -1.293 . . . . 0.54000000000000004 107.509 176.574 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.593 ' N ' ' HG3' ' A' ' 207' ' ' LYS . 17.8 tp10 -100.67 -38.43 8.33 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 116.084 -0.507 . . . . 0.63 110.675 178.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.943 HG22 ' O ' ' A' ' 205' ' ' VAL . 34.2 m -75.01 -30.95 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.208 -0.932 . . . . 0.39000000000000001 112.421 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.648 ' N ' ' HD2' ' A' ' 211' ' ' PRO . 1.3 m -43.45 -45.97 16.16 Favored Pre-proline 0 N--CA 1.51 2.552 0 O-C-N 120.942 -1.099 . . . . 0.42999999999999999 112.142 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.648 ' HD2' ' N ' ' A' ' 210' ' ' THR . 38.1 Cg_endo -60.9 -24.5 79.45 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 O-C-N 122.891 0.943 . . . . 0.34999999999999998 112.706 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.936 HD11 HG22 ' A' ' 96' ' ' ILE . 0.8 OUTLIER -75.11 -18.24 60.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.408 -1.433 . . . . 0.40999999999999998 107.461 176.652 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.957 ' CZ ' HG21 ' A' ' 114' ' ' ILE . 4.6 m-30 -89.57 3.17 53.37 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.437 -0.801 . . . . 0.38 109.68 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -83.1 -43.1 16.63 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.434 -0.792 . . . . 1.22 109.375 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.76 136.19 38.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.402 -0.811 . . . . 0.39000000000000001 110.219 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 91.66 -125.61 8.12 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.114 -1.194 . . . . 0.46000000000000002 110.114 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 21.4 p -148.8 35.15 0.76 Allowed 'General case' 0 N--CA 1.509 2.476 0 O-C-N 121.609 -0.936 . . . . 0.55000000000000004 110.171 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.86 144.98 69.36 Favored Pre-proline 0 C--N 1.291 -1.952 0 O-C-N 121.808 -0.557 . . . . 0.91000000000000003 112.057 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.489 ' HB2' ' HB2' ' A' ' 224' ' ' PHE . 56.2 Cg_endo -78.66 158.8 28.42 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 O-C-N 123.837 1.441 . . . . 0.28000000000000003 108.457 178.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 223' ' ' GLN . 0.0 OUTLIER -80.77 161.81 62.43 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 120.669 -1.269 . . . . 0.37 107.703 178.824 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.639 ' HD3' ' CD2' ' A' ' 213' ' ' PHE . 34.1 Cg_endo -59.69 -44.86 28.52 Favored 'Trans proline' 0 C--N 1.294 -2.342 0 O-C-N 123.791 1.416 . . . . 0.28999999999999998 109.478 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 226' ' ' LEU . 41.9 tt0 -71.02 -42.11 69.99 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 120.24 -0.584 . . . . 1.4299999999999999 111.81 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLN . . . . . 0.513 ' HB3' ' OG1' ' A' ' 220' ' ' THR . 0.0 OUTLIER -66.77 -44.7 80.67 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.049 -1.093 . . . . 0.39000000000000001 108.049 178.852 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.679 ' CE1' ' HB1' ' A' ' 147' ' ' ALA . 62.1 t80 -73.08 -43.49 61.76 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.688 -0.633 . . . . 0.27000000000000002 109.951 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLN . . . . . 0.845 ' O ' HG22 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -59.04 -47.37 85.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -0.92 . . . . 0.59999999999999998 109.711 179.553 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.1 OUTLIER -59.65 -49.98 75.65 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 119.288 -0.965 . . . . 1.1499999999999999 109.325 179.099 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 25.6 m -58.07 -33.25 68.84 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.871 -0.731 . . . . 0.34999999999999998 109.298 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.969 HG12 HG22 ' A' ' 144' ' ' ILE 0.264 1.7 tt -77.88 -53.42 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.053 -1.091 . . . . 0.28999999999999998 108.053 178.147 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.6 ' H ' HG22 ' A' ' 228' ' ' ILE . 5.7 mt-10 -51.37 -38.35 52.82 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.601 -1.259 . . . . 0.46999999999999997 107.601 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 0.5 OUTLIER -54.23 -25.53 23.63 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.184 -0.917 . . . . 0.45000000000000001 110.595 178.67 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 1.02 HG21 ' CB ' ' A' ' 143' ' ' GLU . 3.4 mt -94.75 -19.89 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 118.216 -1.394 . . . . 0.38 107.994 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.744 ' O ' ' HB2' ' A' ' 236' ' ' LEU . . . -78.44 -42.82 28.89 Favored 'General case' 0 C--O 1.198 -1.658 0 N-CA-C 105.589 -2.004 . . . . 0.41999999999999998 105.589 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.615 ' HA ' ' CB ' ' A' ' 236' ' ' LEU 0.275 4.8 m-80 -67.96 -31.56 71.38 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.526 -1.215 . . . . 0.55000000000000004 109.962 177.314 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.534 ' O ' ' NZ ' ' A' ' 234' ' ' LYS . 0.0 OUTLIER -70.11 -44.81 68.21 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.985 -1.116 . . . . 0.66000000000000003 107.985 179.537 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.702 ' HB3' HD11 ' A' ' 130' ' ' LEU . 0.6 OUTLIER -82.04 -17.68 45.86 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 121.773 0.797 . . . . 0.70999999999999996 109.006 177.518 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.759 HD12 ' CD2' ' A' ' 129' ' ' LEU 0.288 24.0 tp -57.58 -60.05 4.26 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 122.358 1.075 . . . . 0.56999999999999995 110.183 178.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLN . . . . . 0.449 ' O ' ' NZ ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -68.57 -90.39 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 114.674 -1.148 . . . . 0.80000000000000004 110.273 -178.514 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.611 ' O ' ' HB3' ' A' ' 239' ' ' ALA . 1.6 m-20 52.38 61.32 3.26 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.34 -0.85 . . . . 0.71999999999999997 110.455 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.611 ' HB3' ' O ' ' A' ' 238' ' ' ASN . . . 69.15 -51.67 0.6 Allowed 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.7 -0.625 . . . . 0.85999999999999999 109.839 -178.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 238' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.96 0 CA-C-O 117.707 -1.14 . . . . 1.1699999999999999 110.942 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 120.966 0.413 . . . . 0.89 110.2 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -141.73 117.72 1.23 Allowed Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.6 -1.4 . . . . 0.8 109.6 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -167.56 167.41 13.55 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.358 -1.084 . . . . 1.5 110.884 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.71 23.01 3.25 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.292 -0.88 . . . . 1.17 110.601 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.613 ' C ' ' HG ' ' A' ' 78' ' ' LEU . 19.4 t -134.64 -40.69 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.724 -0.61 . . . . 0.93 109.695 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.822 ' O ' HG22 ' A' ' 82' ' ' THR . 3.2 pp 36.79 28.82 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 113.749 1.018 . . . . 0.63 113.749 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.5 t -69.58 -176.61 1.04 Allowed 'General case' 0 N--CA 1.506 2.365 0 O-C-N 120.951 -1.093 . . . . 0.71 110.374 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.584 ' O ' ' HB3' ' A' ' 81' ' ' LYS . 0.2 OUTLIER 46.41 75.57 0.12 Allowed 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 108.109 -1.071 . . . . 1.03 108.109 -179.101 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.614 ' O ' ' HB2' ' A' ' 85' ' ' ASP . 0.0 OUTLIER 79.04 91.22 0.06 Allowed 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 106.198 -1.779 . . . . 0.66 106.198 -175.429 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.822 HG22 ' O ' ' A' ' 78' ' ' LEU 0.268 40.4 p -101.11 -60.01 1.6 Allowed 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 123.035 1.398 . . . . 0.53 108.795 -178.017 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.942 HG22 ' CD2' ' A' ' 184' ' ' TYR 0.333 40.9 t -75.04 -48.99 29.96 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 N-CA-C 104.765 -2.309 . . . . 0.46 104.765 176.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.685 ' O ' ' HB2' ' A' ' 88' ' ' LEU 0.283 1.2 tttt -44.46 -34.29 2.0 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 112.749 -2.023 . . . . 1.52 107.621 176.651 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.614 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 5.3 t70 -78.29 -49.38 13.77 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.805 0.812 . . . . 0.41 110.629 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.608 ' HE2' ' HB2' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -68.72 -30.53 69.19 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 108.305 -0.998 . . . . 0.39 108.305 178.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.643 ' N ' ' O ' ' A' ' 83' ' ' VAL . 43.4 ttm -71.98 -35.77 69.61 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.456 -1.683 . . . . 0.69 106.456 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.685 ' HB2' ' O ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -68.76 -41.35 79.01 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.505 -0.77 . . . . 0.52 109.902 177.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.544 ' O ' ' HB3' ' A' ' 93' ' ' SER . 0.0 OUTLIER -67.0 -43.8 81.97 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.574 -1.269 . . . . 1.14 107.574 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -59.5 -54.7 43.62 Favored 'General case' 0 C--O 1.191 -2.001 0 N-CA-C 107.311 -1.366 . . . . 0.45 107.311 177.287 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.687 HD11 ' HA ' ' A' ' 205' ' ' VAL . 7.4 tp -41.64 -48.83 4.15 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.644 0.735 . . . . 0.58 110.81 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -74.5 -44.66 50.36 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.733 0.778 . . . . 0.45 110.244 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.544 ' HB3' ' O ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -78.03 -11.28 59.89 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.082 -0.647 . . . . 0.46 111.511 -178.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.598 ' N ' ' O ' ' A' ' 90' ' ' LYS 0.25 0.4 OUTLIER -76.02 -24.44 55.25 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 106.851 -1.537 . . . . 0.65 106.851 177.127 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.494 ' OD2' ' HA3' ' A' ' 98' ' ' GLY . 44.2 t0 44.2 63.13 1.73 Allowed 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 122.715 1.245 . . . . 0.38 110.861 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.936 HG22 HD11 ' A' ' 212' ' ' LEU 0.324 15.8 mt -47.04 -38.22 4.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 CA-C-N 114.426 -1.261 . . . . 0.52 109.829 178.65 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.431 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 21.4 pttm -78.88 -34.67 44.64 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.069 -1.019 . . . . 0.54 110.741 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.494 ' HA3' ' OD2' ' A' ' 95' ' ' ASP . . . -59.56 -41.46 97.26 Favored Glycine 0 C--N 1.273 -2.933 0 N-CA-C 107.806 -2.118 . . . . 0.31 107.806 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.801 ' HB2' ' CE1' ' A' ' 106' ' ' TYR . 1.3 m120 -69.22 -42.45 75.69 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 106.358 -1.719 . . . . 0.44 106.358 177.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.458 ' CA ' ' HB2' ' A' ' 107' ' ' ALA . . . -60.17 -23.72 64.18 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.846 -0.798 . . . . 0.33 108.846 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 97' ' ' LYS . 5.8 t -81.14 -38.01 27.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.259 -0.901 . . . . 0.51 109.819 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.403 ' HB3' ' HE3' ' A' ' 102' ' ' LYS . 14.9 ttpp -89.85 -28.42 19.28 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.886 0.851 . . . . 0.51 110.167 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' A' ' 106' ' ' TYR . 2.2 m-20 -115.54 103.91 53.6 Favored Pre-proline 0 C--N 1.291 -1.976 0 CA-C-O 121.252 0.548 . . . . 0.59 111.574 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.494 ' HD2' ' HA ' ' A' ' 103' ' ' ASP . 55.5 Cg_endo -71.04 -5.62 17.39 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 124.031 1.543 . . . . 0.42 109.533 177.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -96.55 -39.6 9.46 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 105.709 -1.96 . . . . 0.35 105.709 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.801 ' CE1' ' HB2' ' A' ' 99' ' ' ASN . 26.1 t80 -60.02 -44.9 94.29 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 113.939 -1.482 . . . . 0.34 108.582 177.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.579 ' O ' ' HB2' ' A' ' 111' ' ' CYS . . . -63.04 -38.71 92.28 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.181 -0.918 . . . . 0.32 109.797 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 104' ' ' PRO . 41.7 mtm180 -85.51 -37.35 19.76 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 113.197 0.814 . . . . 0.64 113.197 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.421 ' NE2' ' HA ' ' A' ' 109' ' ' GLN . 2.5 mm100 -77.55 -32.17 53.73 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.15 -0.969 . . . . 0.57 110.694 -178.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.622 HG21 ' CE1' ' A' ' 172' ' ' PHE . 0.2 OUTLIER -94.24 1.74 55.97 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.608 -0.683 . . . . 0.28 110.114 179.292 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . 0.579 ' HB2' ' O ' ' A' ' 107' ' ' ALA . 0.5 OUTLIER -89.79 -36.44 15.14 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 107.875 -1.157 . . . . 0.36 107.875 177.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.661 ' HB3' ' HB3' ' A' ' 153' ' ' LEU . 2.0 mt-10 -89.04 -37.48 15.11 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.768 -0.651 . . . . 0.58 109.319 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.588 ' HA ' ' CB ' ' A' ' 116' ' ' SER . . . -67.48 -27.61 67.16 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 119.41 -0.916 . . . . 0.27 112.017 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.957 HG21 ' CZ ' ' A' ' 213' ' ' PHE . 0.1 OUTLIER -62.61 -49.55 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 CA-C-O 122.388 1.09 . . . . 0.28 108.545 177.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.843 ' O ' HG22 ' A' ' 118' ' ' VAL . 6.6 mt -77.81 -17.4 57.49 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.326 -1.361 . . . . 0.29 107.326 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.619 ' HB3' ' O ' ' A' ' 112' ' ' GLU . 0.9 OUTLIER -78.9 -17.25 55.86 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 106.759 -1.571 . . . . 0.34 106.759 173.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 114' ' ' ILE . . . -76.13 -44.02 40.42 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.723 -1.214 . . . . 0.28 107.723 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.843 HG22 ' O ' ' A' ' 115' ' ' LEU 0.257 11.8 m -66.13 -37.4 79.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 107.181 -1.415 . . . . 0.25 107.181 176.405 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.828 ' HA ' HD11 ' A' ' 228' ' ' ILE . 3.1 t80 -55.36 -55.85 26.88 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 114.321 -1.309 . . . . 0.26 107.473 175.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.718 ' HA ' ' HD2' ' A' ' 123' ' ' LYS . 42.6 t -68.99 -40.7 78.6 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.406 -0.816 . . . . 0.45 109.621 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.663 ' O ' ' HB3' ' A' ' 125' ' ' GLN . 1.2 m-80 -57.07 -39.29 74.66 Favored 'General case' 0 C--O 1.192 -1.928 0 N-CA-C 106.573 -1.639 . . . . 0.39 106.573 177.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.864 ' CG ' HG23 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -60.96 -43.63 98.44 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.639 -0.824 . . . . 0.33 109.714 178.033 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.718 ' HD2' ' HA ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -74.82 -12.7 60.45 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 118.115 -1.434 . . . . 0.63 109.112 179.636 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.602 ' O ' ' HB2' ' A' ' 128' ' ' LYS 0.264 32.3 t70 -95.64 -43.78 7.76 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 122.479 1.133 . . . . 0.81 109.513 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.663 ' HB3' ' O ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER -73.58 -48.96 28.81 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 114.741 -1.118 . . . . 0.78 109.007 -179.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.65 ' SG ' ' HA ' ' A' ' 232' ' ' ALA . 17.6 t -67.21 -53.55 29.23 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.787 -0.819 . . . . 0.48 108.787 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.786 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 42.6 t -58.78 -28.4 65.92 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 119.418 -0.913 . . . . 0.59 111.342 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.602 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -53.83 -57.51 10.65 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.098 -1.001 . . . . 1.02 110.666 -179.531 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.759 ' CD2' HD12 ' A' ' 236' ' ' LEU . 0.3 OUTLIER -78.61 -26.07 45.26 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 122.145 0.974 . . . . 0.63 109.923 179.349 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 1.035 HD22 HG11 ' A' ' 135' ' ' VAL . 6.7 mt -67.64 -37.31 82.26 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.541 0.686 . . . . 0.68 110.934 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.8 tp -64.27 -12.0 11.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.371 -0.974 . . . . 0.92 108.371 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.5 p -90.07 -34.74 15.81 Favored 'General case' 0 C--N 1.314 -0.973 0 O-C-N 121.798 -0.564 . . . . 0.84 109.98 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.748 ' HE3' HD12 ' A' ' 129' ' ' LEU . 15.4 mttt -81.02 -24.22 38.07 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.907 0.861 . . . . 0.85 109.092 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.92 38.4 10.42 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 107.382 -2.287 . . . . 0.82 107.382 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 1.035 HG11 HD22 ' A' ' 130' ' ' LEU 0.296 0.3 OUTLIER -82.82 -150.03 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-O 122.405 1.098 . . . . 0.72 112.332 -177.592 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.876 ' N ' HG13 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -147.89 101.62 3.32 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.27 -1.011 . . . . 0.81 108.27 178.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.455 ' H ' HG23 ' A' ' 137' ' ' ILE . 2.1 pt -76.9 -15.67 14.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 O-C-N 121.678 -0.639 . . . . 0.71 111.674 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.633 ' N ' ' HD2' ' A' ' 139' ' ' PRO . 18.6 m -54.75 -48.82 94.5 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.56 -0.713 . . . . 0.57 109.25 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.656 ' O ' ' HB3' ' A' ' 142' ' ' LYS . 34.6 Cg_endo -61.84 -38.53 58.71 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 N-CA-C 108.869 -1.243 . . . . 0.54 108.869 177.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.943 ' HD1' HG22 ' A' ' 231' ' ' ILE . 4.3 t80 -68.35 -43.32 77.72 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.017 -1.105 . . . . 0.41 108.017 176.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.735 ' HA ' HD11 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -55.49 -39.98 71.11 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.495 -1.298 . . . . 0.57 107.495 176.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.656 ' HB3' ' O ' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -53.02 -40.64 64.01 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.95 -0.759 . . . . 0.45 108.95 177.196 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 1.02 ' CB ' HG21 ' A' ' 231' ' ' ILE . 0.4 OUTLIER -70.31 -54.94 10.53 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 121.434 -0.791 . . . . 0.48 110.497 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.969 HG22 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -58.67 -30.02 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 117.65 -1.62 . . . . 0.4 109.016 178.467 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.83 ' HA2' ' HB3' ' A' ' 148' ' ' ALA . . . -62.84 -25.53 67.78 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.617 -1.793 . . . . 0.26 108.617 176.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 150' ' ' ASN 0.256 6.5 tp10 -65.83 -60.29 3.02 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 123.372 1.558 . . . . 0.43 106.998 177.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.679 ' HB1' ' CE1' ' A' ' 224' ' ' PHE . . . -55.03 -40.41 70.19 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 112.985 -1.916 . . . . 0.27 106.21 176.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.849 ' HB1' ' HB3' ' A' ' 164' ' ' PRO . . . -68.55 -15.54 63.57 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.248 0.547 . . . . 0.27 110.946 178.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.463 ' N ' ' O ' ' A' ' 145' ' ' GLY . 12.4 tt0 -97.52 -44.48 6.8 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 123.167 1.461 . . . . 0.37 107.97 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.533 ' ND2' ' HA ' ' A' ' 147' ' ' ALA 0.251 0.0 OUTLIER -73.54 -29.79 62.67 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 113.627 -1.624 . . . . 0.46 110.343 179.813 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.661 ' HB2' ' CE1' ' A' ' 224' ' ' PHE . . . -73.4 -18.4 61.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.382 -0.824 . . . . 0.37 110.184 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.443 ' C ' ' HD3' ' A' ' 154' ' ' PRO . . . 107.32 18.14 10.67 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.969 -1.11 . . . . 0.42 112.745 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.661 ' HB3' ' HB3' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -127.26 68.95 73.72 Favored Pre-proline 0 N--CA 1.51 2.532 0 CA-C-N 119.25 1.525 . . . . 0.45 111.646 179.161 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.465 ' HA ' ' CZ ' ' A' ' 162' ' ' PHE . 51.3 Cg_endo -97.15 179.76 0.41 Allowed 'Trans proline' 0 C--N 1.317 -1.1 0 C-N-CA 122.306 2.004 . . . . 0.5 111.088 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 149.19 -7.53 0.87 Allowed Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.708 -1.234 . . . . 0.56 112.783 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.676 ' CB ' ' HB ' ' A' ' 163' ' ' THR . 0.1 OUTLIER -145.61 146.98 31.56 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 120.661 -1.493 . . . . 0.9 111.038 -179.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.665 ' HA ' ' HA ' ' A' ' 162' ' ' PHE 0.269 0.0 OUTLIER -162.51 146.44 3.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.553 -0.717 . . . . 0.62 109.442 -179.207 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.593 ' HB2' HG12 ' A' ' 161' ' ' VAL . 0.9 OUTLIER -139.42 -132.5 0.12 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.748 -1.22 . . . . 0.65 111.055 -178.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -63.3 76.87 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.24 -0.913 . . . . 1.28 111.448 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 64.89 31.25 80.31 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.167 -1.173 . . . . 0.75 110.167 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.593 HG12 ' HB2' ' A' ' 158' ' ' LYS . 1.2 p -139.57 146.05 25.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.873 -0.78 . . . . 0.56 110.126 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.665 ' HA ' ' HA ' ' A' ' 157' ' ' ILE . 0.1 OUTLIER -122.4 154.59 37.52 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.194 0.997 . . . . 0.43 110.745 179.346 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.676 ' HB ' ' CB ' ' A' ' 156' ' ' GLU . 3.6 m -131.93 139.59 35.53 Favored Pre-proline 0 C--N 1.296 -1.748 0 N-CA-C 108.188 -1.041 . . . . 0.49 108.188 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.849 ' HB3' ' HB1' ' A' ' 148' ' ' ALA . 38.2 Cg_endo -64.86 149.25 89.84 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.437 1.23 . . . . 0.34 111.273 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -62.87 -83.87 0.07 OUTLIER Glycine 0 N--CA 1.499 2.854 0 N-CA-C 111.043 -0.823 . . . . 0.47 111.043 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -73.13 66.77 1.48 Allowed Glycine 0 N--CA 1.5 2.936 0 N-CA-C 109.914 -1.274 . . . . 0.68 109.914 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.739 ' HB2' ' HG2' ' A' ' 164' ' ' PRO . . . -102.76 98.87 8.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.675 -0.897 . . . . 0.65 110.389 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -123.92 -141.36 5.78 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.798 -0.921 . . . . 0.58 110.798 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 170' ' ' ASN . . . -113.56 45.32 1.44 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.669 -0.9 . . . . 0.54 110.67 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.606 ' HB3' ' HB ' ' A' ' 173' ' ' VAL . 11.5 t-20 71.32 102.49 0.03 OUTLIER Pre-proline 0 N--CA 1.508 2.452 0 O-C-N 121.888 -0.508 . . . . 0.38 112.053 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.611 ' CG ' HG23 ' A' ' 110' ' ' THR . 40.4 Cg_endo -66.03 -21.88 55.81 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 O-C-N 123.544 1.286 . . . . 0.42 111.604 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.906 ' CE1' HG23 ' A' ' 96' ' ' ILE . 28.0 m-85 -80.16 -48.09 13.7 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.407 -0.96 . . . . 0.42 108.407 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.682 ' HA ' ' HB3' ' A' ' 176' ' ' LEU . 37.4 t -70.79 -35.89 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-N 115.978 -0.555 . . . . 0.47 111.508 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.604 ' HB ' ' HD3' ' A' ' 175' ' ' PRO . 2.9 t -44.5 -61.76 1.95 Allowed Pre-proline 0 N--CA 1.501 2.115 0 O-C-N 121.007 -1.058 . . . . 0.46 111.486 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.703 ' HA ' ' HB3' ' A' ' 178' ' ' ALA . 40.4 Cg_endo -75.88 -26.54 9.47 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 O-C-N 123.048 1.026 . . . . 0.35 110.716 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.71 HD23 HG12 ' A' ' 177' ' ' ILE . 0.4 OUTLIER -63.82 -51.74 63.33 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 105.785 -1.932 . . . . 0.43 105.785 177.504 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.71 HG12 HD23 ' A' ' 176' ' ' LEU . 5.5 mm -71.97 -31.11 39.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-N 114.953 -1.021 . . . . 0.57 109.701 177.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.703 ' HB3' ' HA ' ' A' ' 175' ' ' PRO . . . -64.18 -42.78 96.53 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.132 -1.062 . . . . 0.57 108.132 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 183' ' ' LYS . 25.4 p -63.37 -51.98 63.64 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.594 -0.842 . . . . 0.5 108.853 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.608 ' HB2' ' HE2' ' A' ' 86' ' ' PHE . . . -61.75 -24.92 67.13 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 121.714 -0.616 . . . . 0.55 111.509 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 65.9 m -77.35 -32.23 54.93 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.117 -1.438 . . . . 0.74 107.117 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.456 ' HB ' ' O ' ' A' ' 178' ' ' ALA 0.31 0.1 OUTLIER -81.23 -35.51 14.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 114.389 -1.278 . . . . 0.74 109.177 178.018 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.994 ' HG2' ' CD2' ' A' ' 184' ' ' TYR 0.262 0.0 OUTLIER -81.85 -54.44 5.35 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.065 -0.971 . . . . 0.63 110.651 -178.812 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.994 ' CD2' ' HG2' ' A' ' 183' ' ' LYS . 42.7 m-85 -100.96 83.36 0.41 Allowed Pre-proline 0 C--N 1.292 -1.925 0 CA-C-N 115.503 -0.771 . . . . 0.67 112.993 -178.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.19 -40.41 8.71 Favored 'Trans proline' 0 C--N 1.299 -2.079 0 N-CA-C 107.596 -1.732 . . . . 0.86 107.596 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 1.078 ' HA ' HD12 ' A' ' 189' ' ' ILE . 22.7 t60 -56.46 -48.97 75.95 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 113.536 0.939 . . . . 1.07 113.536 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . 0.619 ' HB3' ' CE2' ' A' ' 197' ' ' PHE . 1.9 mmt -79.33 -25.49 42.32 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 121.549 0.69 . . . . 1.12 110.233 -178.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . 0.576 ' HD2' ' HB2' ' A' ' 194' ' ' GLN . 28.0 m-85 -95.07 -2.66 49.68 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.384 -0.822 . . . . 0.82 111.475 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 1.078 HD12 ' HA ' ' A' ' 186' ' ' HIS . 0.5 OUTLIER -53.56 -47.35 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 O-C-N 121.487 -0.758 . . . . 1.1 111.194 179.429 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.428 ' HB2' ' OE1' ' A' ' 193' ' ' GLN . 10.5 m-20 -68.26 131.93 46.23 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 122.064 0.935 . . . . 1.68 110.96 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.546 ' C ' ' CD2' ' A' ' 191' ' ' HIS . 0.1 OUTLIER -54.28 -29.22 46.47 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.526 -0.761 . . . . 1.36 111.773 -178.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -94.89 -16.76 22.62 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.676 -1.265 . . . . 1.38 111.797 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.472 ' HB3' ' O ' ' A' ' 187' ' ' MET . 19.1 mt-30 -68.27 -46.63 69.88 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.881 -1.137 . . . . 1.0 111.729 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.576 ' HB2' ' HD2' ' A' ' 188' ' ' PHE . 0.0 OUTLIER -68.66 -27.85 66.36 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.501 -1.375 . . . . 0.95 109.266 179.015 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.673 ' HA ' ' HD3' ' A' ' 198' ' ' LYS . 0.9 OUTLIER -72.18 -42.68 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 107.696 -1.224 . . . . 0.97 107.696 177.112 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.43 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 0.5 OUTLIER -71.96 -33.7 68.4 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.154 -0.966 . . . . 0.92 109.348 178.585 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.648 ' HB3' ' CD1' ' A' ' 177' ' ' ILE . 0.4 OUTLIER -53.72 -44.4 69.85 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.506 0.669 . . . . 0.63 111.038 179.393 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.673 ' HD3' ' HA ' ' A' ' 195' ' ' VAL . 3.6 pttm -70.64 -16.11 62.79 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.212 0.529 . . . . 1.09 110.539 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.515 ' O ' ' HG3' ' A' ' 202' ' ' GLU . . . -71.43 -50.72 29.0 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.272 -0.971 . . . . 0.75 109.908 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.614 ' CE1' ' HG3' ' A' ' 84' ' ' LYS . 4.4 p90 -79.86 -11.69 59.8 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 117.685 -1.606 . . . . 0.58 107.973 176.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.66 ' HB3' ' HA ' ' A' ' 198' ' ' LYS . . . -73.27 -41.69 63.33 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.691 -0.855 . . . . 0.5 108.691 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.587 ' O ' HG22 ' A' ' 205' ' ' VAL . 0.0 OUTLIER -69.29 -16.98 63.68 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.195 -1.402 . . . . 1.14 108.992 178.341 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 203' ' ' LYS . 1.2 tppt? -78.9 -32.06 45.61 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.97 -1.081 . . . . 0.7 111.376 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.497 ' HB ' HD22 ' A' ' 91' ' ' LEU . 5.4 pt -77.11 -43.4 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 120.8 -1.188 . . . . 0.42 110.136 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.943 ' O ' HG22 ' A' ' 209' ' ' VAL . 25.3 m -50.26 -33.4 10.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 C-N-CA 119.116 -1.033 . . . . 0.38 108.736 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' MET . . . . . 0.801 ' HA ' ' CG2' ' A' ' 209' ' ' VAL . 0.8 OUTLIER -53.99 -16.81 2.1 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.872 -0.731 . . . . 1.42 111.125 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.593 ' HG3' ' N ' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -88.78 -24.43 22.63 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.509 -1.293 . . . . 0.54 107.509 176.574 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.593 ' N ' ' HG3' ' A' ' 207' ' ' LYS . 17.8 tp10 -100.67 -38.43 8.33 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 116.084 -0.507 . . . . 0.63 110.675 178.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.943 HG22 ' O ' ' A' ' 205' ' ' VAL . 34.2 m -75.01 -30.95 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.208 -0.932 . . . . 0.39 112.421 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.648 ' N ' ' HD2' ' A' ' 211' ' ' PRO . 1.3 m -43.45 -45.97 16.16 Favored Pre-proline 0 N--CA 1.51 2.552 0 O-C-N 120.942 -1.099 . . . . 0.43 112.142 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.648 ' HD2' ' N ' ' A' ' 210' ' ' THR . 38.1 Cg_endo -60.9 -24.5 79.45 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 O-C-N 122.891 0.943 . . . . 0.35 112.706 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.936 HD11 HG22 ' A' ' 96' ' ' ILE . 0.8 OUTLIER -75.11 -18.24 60.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.408 -1.433 . . . . 0.41 107.461 176.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.957 ' CZ ' HG21 ' A' ' 114' ' ' ILE . 4.6 m-30 -89.57 3.17 53.37 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.437 -0.801 . . . . 0.38 109.68 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -83.1 -43.1 16.63 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.434 -0.792 . . . . 1.22 109.375 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.76 136.19 38.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.402 -0.811 . . . . 0.39 110.219 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 91.66 -125.61 8.12 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.114 -1.194 . . . . 0.46 110.114 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 21.4 p -148.8 35.15 0.76 Allowed 'General case' 0 N--CA 1.509 2.476 0 O-C-N 121.609 -0.936 . . . . 0.55 110.171 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.86 144.98 69.36 Favored Pre-proline 0 C--N 1.291 -1.952 0 O-C-N 121.808 -0.557 . . . . 0.91 112.057 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.489 ' HB2' ' HB2' ' A' ' 224' ' ' PHE . 56.2 Cg_endo -78.66 158.8 28.42 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 O-C-N 123.837 1.441 . . . . 0.28 108.457 178.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 223' ' ' GLN . 0.0 OUTLIER -80.77 161.81 62.43 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 120.669 -1.269 . . . . 0.37 107.703 178.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.639 ' HD3' ' CD2' ' A' ' 213' ' ' PHE . 34.1 Cg_endo -59.69 -44.86 28.52 Favored 'Trans proline' 0 C--N 1.294 -2.342 0 O-C-N 123.791 1.416 . . . . 0.29 109.478 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 226' ' ' LEU . 41.9 tt0 -71.02 -42.11 69.99 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 120.24 -0.584 . . . . 1.43 111.81 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.513 ' HB3' ' OG1' ' A' ' 220' ' ' THR . 0.0 OUTLIER -66.77 -44.7 80.67 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.049 -1.093 . . . . 0.39 108.049 178.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.679 ' CE1' ' HB1' ' A' ' 147' ' ' ALA . 62.1 t80 -73.08 -43.49 61.76 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.688 -0.633 . . . . 0.27 109.951 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . 0.845 ' O ' HG22 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -59.04 -47.37 85.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -0.92 . . . . 0.6 109.711 179.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.1 OUTLIER -59.65 -49.98 75.65 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 119.288 -0.965 . . . . 1.15 109.325 179.099 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 25.6 m -58.07 -33.25 68.84 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.871 -0.731 . . . . 0.35 109.298 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.969 HG12 HG22 ' A' ' 144' ' ' ILE 0.264 1.7 tt -77.88 -53.42 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.053 -1.091 . . . . 0.29 108.053 178.147 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.6 ' H ' HG22 ' A' ' 228' ' ' ILE . 5.7 mt-10 -51.37 -38.35 52.82 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.601 -1.259 . . . . 0.47 107.601 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 0.5 OUTLIER -54.23 -25.53 23.63 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.184 -0.917 . . . . 0.45 110.595 178.67 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 1.02 HG21 ' CB ' ' A' ' 143' ' ' GLU . 3.4 mt -94.75 -19.89 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 118.216 -1.394 . . . . 0.38 107.994 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.744 ' O ' ' HB2' ' A' ' 236' ' ' LEU . . . -78.44 -42.82 28.89 Favored 'General case' 0 C--O 1.198 -1.658 0 N-CA-C 105.589 -2.004 . . . . 0.42 105.589 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.615 ' HA ' ' CB ' ' A' ' 236' ' ' LEU 0.275 4.8 m-80 -67.96 -31.56 71.38 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.526 -1.215 . . . . 0.55 109.962 177.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.534 ' O ' ' NZ ' ' A' ' 234' ' ' LYS . 0.0 OUTLIER -70.11 -44.81 68.21 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.985 -1.116 . . . . 0.66 107.985 179.537 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.702 ' HB3' HD11 ' A' ' 130' ' ' LEU . 0.6 OUTLIER -82.04 -17.68 45.86 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 121.773 0.797 . . . . 0.71 109.006 177.518 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.759 HD12 ' CD2' ' A' ' 129' ' ' LEU 0.288 24.0 tp -57.58 -60.05 4.26 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 122.358 1.075 . . . . 0.57 110.183 178.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLN . . . . . 0.449 ' O ' ' NZ ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -68.57 -90.39 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 114.674 -1.148 . . . . 0.8 110.273 -178.514 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.611 ' O ' ' HB3' ' A' ' 239' ' ' ALA . 1.6 m-20 52.38 61.32 3.26 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.34 -0.85 . . . . 0.72 110.455 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.611 ' HB3' ' O ' ' A' ' 238' ' ' ASN . . . 69.15 -51.67 0.6 Allowed 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.7 -0.625 . . . . 0.86 109.839 -178.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 238' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.96 0 CA-C-O 117.707 -1.14 . . . . 1.17 110.942 179.258 . . . . . . . . 2 2 . 1 stop_ save_